USPTO serial 88871012
PEPTERON
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RAFARI-PEARSON, NIYA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PEPTERON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nancy J. Flint, Esq.
Nancy J. Flint, Esq. NANCY J. FLINT, ATTORNEY AT LAW, P.A.1580 Sawgrass Corporate ParkwaySuite 130Sunrise, FL 33323Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Homeopathic pharmaceuticals for use in the treatment of pain; Homeopathic pharmaceuticals for use in fever reduction; Homeopathic pharmaceuticals for use in the treatment of inflammation; Homeopathic pharmaceuticals for use in the treatment of colds; Homeopathic pharmaceuticals for use in the treatment of flu; Pharmaceutical preparations for pain relief; Pharmaceutical preparations for fever reduction; Pharmaceutical preparations for treatment of inflammation; Pharmaceutical preparations for treatment of colds; Pharmaceutical preparations for treatment of flu; Pharmaceutical preparations for use as immune stimulants; Veterinary preparations, namely, pain relief, anti-inflammatory and fever reduction medication; Antiinflammatory preparations; Injectable pharmaceuticals for use in the treatment of pain; Injectable pharmaceuticals for use in fever reduction; Injectable pharmaceuticals for use in the treatment of inflammation; nasal spray preparations; nasal spray for the treatment of pain; nasal spray for use in fever reduction; nasal spray for use in the treatment of inflammation; topical analgesic creams; pharmaceutical preparations, namely, topical gels for treatment of inflammation; pharmaceutical preparations, namely, topical gels for fever reduction; preparations for treating colds; all of the foregoing containing only homeopathic or natural ingredients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 16, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 16, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 9, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 9, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 9, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 3, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 3, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 3, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 17, 2020 | NWAP | NEW APPLICATION ENTERED | — |